These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25212176)

  • 1. Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.
    Soysal SD; Muenst S; Kan-Mitchell J; Huarte E; Zhang X; Wilkinson-Ryan I; Fleming T; Tiriveedhi V; Mohanakumar T; Li L; Herndon J; Oertli D; Goedegebuure SP; Gillanders WE
    Breast Cancer Res Treat; 2014 Oct; 147(3):527-37. PubMed ID: 25212176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.
    Tiriveedhi V; Tucker N; Herndon J; Li L; Sturmoski M; Ellis M; Ma C; Naughton M; Lockhart AC; Gao F; Fleming T; Goedegebuure P; Mohanakumar T; Gillanders WE
    Clin Cancer Res; 2014 Dec; 20(23):5964-75. PubMed ID: 25451106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.
    Tiriveedhi V; Sarma NJ; Subramanian V; Fleming TP; Gillanders WE; Mohanakumar T
    Hum Immunol; 2012 Jan; 73(1):11-6. PubMed ID: 22074997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
    Narayanan K; Jaramillo A; Benshoff ND; Campbell LG; Fleming TP; Dietz JR; Mohanakumar T
    J Natl Cancer Inst; 2004 Sep; 96(18):1388-96. PubMed ID: 15367572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
    Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
    Bharat A; Benshoff N; Fleming TP; Dietz JR; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2008 Aug; 110(3):453-63. PubMed ID: 17874294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells.
    Tiriveedhi V; Fleming TP; Goedegebuure PS; Naughton M; Ma C; Lockhart C; Gao F; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2013 Feb; 138(1):109-18. PubMed ID: 22678162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer.
    Jaramillo A; Majumder K; Manna PP; Fleming TP; Doherty G; Dipersio JF; Mohanakumar T
    Int J Cancer; 2002 Dec; 102(5):499-506. PubMed ID: 12432553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors.
    Lerret NM; Rogozinska M; Jaramillo A; Marzo AL
    PLoS One; 2012; 7(7):e41240. PubMed ID: 22911764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.
    Ilias Basha H; Tiriveedhi V; Fleming TP; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2011 May; 127(1):81-9. PubMed ID: 20544273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells.
    Oh S; Terabe M; Pendleton CD; Bhattacharyya A; Bera TK; Epel M; Reiter Y; Phillips J; Linehan WM; Kasten-Sportes C; Pastan I; Berzofsky JA
    Cancer Res; 2004 Apr; 64(7):2610-8. PubMed ID: 15059918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8
    Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M
    Front Immunol; 2018; 9():2968. PubMed ID: 30631324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of mammaglobin-A epitope in heterogenous breast cancers for enhancing tumor-targeting therapy.
    Liu Z; Yang X; Duan C; Li J; Tong R; Fan Y; Feng J; Cao R; Zhong W; Feng X; Zhang H; Cai L
    Signal Transduct Target Ther; 2020 May; 5(1):82. PubMed ID: 32467564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
    Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
    Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
    Smith HA; Rekoske BT; McNeel DG
    Vaccine; 2014 Mar; 32(15):1707-15. PubMed ID: 24492013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies.
    Viehl CT; Frey DM; Phommaly C; Chen T; Fleming TP; Gillanders WE; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2008 May; 109(2):305-14. PubMed ID: 17653857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
    Singh R; Paterson Y
    Cancer Res; 2006 Aug; 66(15):7748-57. PubMed ID: 16885378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.
    Hung CF; Calizo R; Tsai YC; He L; Wu TC
    Vaccine; 2007 Jan; 25(1):127-35. PubMed ID: 16930783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.
    Smith HA; McNeel DG
    J Immunother; 2011 Oct; 34(8):569-80. PubMed ID: 21904219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.
    Tanaka Y; Amos KD; Fleming TP; Eberlein TJ; Goedegebuure PS
    Surgery; 2003 Jan; 133(1):74-80. PubMed ID: 12563241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.